Skip to main content
. Author manuscript; available in PMC: 2025 Apr 1.
Published in final edited form as: JCO Precis Oncol. 2024 Apr;8:e2300567. doi: 10.1200/PO.23.00567

Figure 2.

Figure 2.

Figure 2.

(A) Sankey flow diagram showing crossover between blood (plasma circulating tumor DNA assays) and tissue tests with the percentage of tests in bold and percentage with an actionable finding underneath. (B) The most common serial sequencing patterns, where B represents a blood test and T represents a tissue test i.e. TB indicates the first Next Generation Sequencing (NGS) test was tissue and the second NGS test was blood (plasma).